Yves Bonhomme
Director/Board Member at Bellus Health (Innodia), Inc.
Profile
Yves Bonhomme is a Director of Innodia, Inc. Prior to joining Innodia, he was Managing Director and Head of Research and Development for Lipha SA until 2002 and Chairman of Lyon University School of Pharmacy from 1997 to 2001.
Dr. Bonhomme has diabetes research and product development experience.
He received an undergraduate degree from INSEAD.
Yves Bonhomme active positions
| Companies | Position | Start |
|---|---|---|
Bellus Health (Innodia), Inc.
 Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Director/Board Member | - |
Former positions of Yves Bonhomme
| Companies | Position | End |
|---|---|---|
| University of Lyon | Corporate Officer/Principal | 2000-12-31 |
Training of Yves Bonhomme
| INSEAD | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Bellus Health (Innodia), Inc.
Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Health Technology |
- Stock Market
- Insiders
- Yves Bonhomme
